Source: Annual Congress 2008 - Markers and triggers of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Pur Ozyigit, A. Yakar, G. Okumus, E. Kiyan (Istanbul, Turkey). A case of laryngo-tracheal amyloidosis, evaluated as refractory asthma. Eur Respir J 2008; 32: Suppl. 52, 484

Member's Comments

No comment yet.

Related content which might interest you: Follow-up of the patients with newly diagnosed sarcoidosis treated with oral corticosteroids. Features associated with chronic sarcoidosis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Super-response to dupilumab therapy in a patient with severe asthma and ABPA – a case report Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Oropharyngeal swallowing pathophysiology in patients with idiopathic pulmonary fibrosis: A consecutive descriptive case series. Source: Virtual Congress 2020 – Imaging evaluation of chronic lung diseases Year: 2020 Respiratory subtype of relapsing polychondritis frequently presents as difficult asthma: a descriptive study of respiratory involvement in relapsing polychondritis with 13 patients from a single UK centre Source: ERJ Open Res, 7 (1) 00170-2020; 10.1183/23120541.00170-2020 Year: 2021 Combined immunosuppressive therapy including anti-TNFα in a treatment of severe paediatric sarcoidosis – a case report Source: Eur Respir J 2006; 28: Suppl. 50, 829s Year: 2006 Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Source: Eur Respir J 2003; 22: 8-13 Year: 2003 Effect of itraconazole therapy on disease course in 3 cases of allergic bronchopulmonary mycosis presented as refractory asthma Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008 A rare case of idiopathic pulmonary fibrosis in children Source: Eur Respir J 2007; 30: Suppl. 51, 390s Year: 2007 Eosinophilic refractory inflammation in OCS-dependent severe asthma Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia Source: Eur Respir J 2013; 41: 402-409 Year: 2013 Effect of ABPA treatment in severe asthma patients with acute and relapsed disease Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Progressive case of recurrent respiratory papillomatosis successfully treated with gefitinib Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Prevalence of adrenal insufficiency in patients started on Mepolizumab for severe eosinophilic asthma. Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 The characteristics of treatment failure with omalizumab in patients with severe asthma: The impact of eosinophilic complication Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study Source: Eur Respir J 2012; 40: 101-109 Year: 2012 Recurrent eosinophilic pneumonia in an asthmatic patient treated with sequential montelukast/zafirlukast after corticosteroid withdrawal Source: Eur Respir J 2002; 20: Suppl. 38, 52s Year: 2002 Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Clinical features of steroid-resistant patients with severe steroid-dependent bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 133s Year: 2004 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011